Suppr超能文献

高危型和低危型人乳头瘤病毒E7癌蛋白之间的生化及生物学差异由氨基末端序列决定。

Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.

作者信息

Münger K, Yee C L, Phelps W C, Pietenpol J A, Moses H L, Howley P M

机构信息

Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

J Virol. 1991 Jul;65(7):3943-8. doi: 10.1128/JVI.65.7.3943-3948.1991.

Abstract

Differences in the biological characteristics of the high-risk human papillomavirus type 16 (HPV-16) and the low-risk HPV-6 E7 proteins were analyzed and shown to correlate with certain biochemical properties. To ascertain which region of E7 conferred these properties, chimeric E7 genes were constructed by the exchange of the amino and carboxyl coding halves of the HPV-6 and HPV-16 E7 genes. The amino-terminal half of E7 determined the affinity for binding to the retinoblastoma protein pRB, the transformation properties, and the ability to abrogate transforming growth factor beta-mediated repression of the c-myc promoter. This region of E7 is therefore responsible for the biological and biochemical differences between the E7 proteins of the low-risk and the high-risk HPVs and consequently is one of the critical determinants distinguishing these two groups of viruses. Transcriptional transactivation of the adenovirus E2 promoter, in contrast, was a property shared by E7 proteins of both low-risk and high-risk HPVs.

摘要

对高危人乳头瘤病毒16型(HPV - 16)和低危HPV - 6 E7蛋白的生物学特性差异进行了分析,并表明这些差异与某些生化特性相关。为了确定E7的哪个区域赋予了这些特性,通过交换HPV - 6和HPV - 16 E7基因的氨基和羧基编码半段构建了嵌合E7基因。E7的氨基末端半段决定了与视网膜母细胞瘤蛋白pRB结合的亲和力、转化特性以及消除转化生长因子β介导的c - myc启动子抑制的能力。因此,E7的这一区域是低危和高危HPV的E7蛋白之间生物学和生化差异的原因,因而也是区分这两组病毒的关键决定因素之一。相比之下,腺病毒E2启动子的转录反式激活是低危和高危HPV的E7蛋白共有的特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e613/241434/6a92b5cecb0e/jvirol00050-0541-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验